Toby Rogers, MD, PhD, noted that BASILICA is a fairly complex procedure. Using this advanced technology, however, could make it easier to perform and improve patient access.

The FDA thinks 24/7 fitness trackers from Boston-based Whoop should be regulated like medical devices. Whoop disagrees, however, and neither side appears to be changing its mind. 

Women are associated with a significantly higher rate of in-hospital disabling strokes than men, according to a new study of nearly 380,000 TAVR patients. What can cardiologists do to help limit these complications? 

The company's automated insulin pump can now be used to treat more patients thanks to an expanded CE mark approval. Could updates from the FDA be next?

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 

A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.

One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms. 

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus. 

Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients. 

Experts suggest abnormal findings on cardiopulmonary PET/MR should be considered a risk factor for long-term complications in COVID patients. 

Not only could its use reduce wait times, but it also could cut the associated costs of imaging.